Ford-Siltz Lauren A, Wales Samantha, Tohma Kentaro, Gao Yamei, Parra Gabriel I
Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
Center for Food Safety and Applied Nutrition, Food and Drug Administration, Laurel, Maryland, USA.
J Infect Dis. 2022 Apr 1;225(7):1205-1214. doi: 10.1093/infdis/jiaa116.
Human noroviruses are the most common viral agents of acute gastroenteritis. Recently, human intestinal enteroids were shown to be permissive for norovirus infection. We tested their suitability as a system to study norovirus neutralization. Hyperimmune sera raised against virus-like particles (VLPs) representing different genotypes showed highly specific neutralization activity against GII.4 and GII.6 noroviruses. Carbohydrate blocking assays and neutralization exhibited similar patterns in antibody responses. Notably, sera produced against chimeric VLPs that presented swapped structural shell and protruding (P) domains, from different genotypes showed that neutralization is primarily mediated by antibodies mapping to the P domain of the norovirus capsid protein. This study provides empirical information on the antigenic differences among genotypes as measured by neutralization, which could guide vaccine design.
人诺如病毒是急性胃肠炎最常见的病毒病原体。最近,研究表明人肠道类器官对诺如病毒感染具有易感性。我们测试了它们作为研究诺如病毒中和作用系统的适用性。针对代表不同基因型的病毒样颗粒(VLP)产生的超免疫血清对GII.4和GII.6诺如病毒表现出高度特异性的中和活性。碳水化合物阻断试验和中和试验在抗体反应中表现出相似的模式。值得注意的是,针对呈现不同基因型的结构外壳和突出(P)结构域互换的嵌合VLP产生的血清表明,中和作用主要由映射到诺如病毒衣壳蛋白P结构域的抗体介导。这项研究提供了通过中和作用测量的不同基因型之间抗原差异的实证信息,这可为疫苗设计提供指导。